ATE62597T1 - Ein neocarzinostatinderivat enthaltende zusammensetzungen zur oralen verabreichung. - Google Patents

Ein neocarzinostatinderivat enthaltende zusammensetzungen zur oralen verabreichung.

Info

Publication number
ATE62597T1
ATE62597T1 AT87306751T AT87306751T ATE62597T1 AT E62597 T1 ATE62597 T1 AT E62597T1 AT 87306751 T AT87306751 T AT 87306751T AT 87306751 T AT87306751 T AT 87306751T AT E62597 T1 ATE62597 T1 AT E62597T1
Authority
AT
Austria
Prior art keywords
neocarzinostat
compositions
individual
oral administration
administration containing
Prior art date
Application number
AT87306751T
Other languages
English (en)
Inventor
Hiroshi Maeda
Fusio Suzuki
Kiichiro Oka
Shohei Tanaka
Original Assignee
Yamanouchi Pharma Co Ltd
Hiroshi Maeda
Kuraray Co
Kayaku Antibiotic Research Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd, Hiroshi Maeda, Kuraray Co, Kayaku Antibiotic Research Co filed Critical Yamanouchi Pharma Co Ltd
Application granted granted Critical
Publication of ATE62597T1 publication Critical patent/ATE62597T1/de

Links

Classifications

    • G—PHYSICS
    • G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
    • G03C1/00—Photosensitive materials
    • G03C1/005—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein
    • G03C1/485—Direct positive emulsions
    • G03C1/48515—Direct positive emulsions prefogged
    • G03C1/48523—Direct positive emulsions prefogged characterised by the desensitiser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S430/00—Radiation imagery chemistry: process, composition, or product thereof
    • Y10S430/141—Direct positive material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT87306751T 1986-09-19 1987-07-30 Ein neocarzinostatinderivat enthaltende zusammensetzungen zur oralen verabreichung. ATE62597T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP22116686 1986-09-19
EP87306751A EP0260796B1 (de) 1986-09-19 1987-07-30 Ein Neocarzinostatinderivat enthaltende Zusammensetzungen zur oralen Verabreichung

Publications (1)

Publication Number Publication Date
ATE62597T1 true ATE62597T1 (de) 1991-05-15

Family

ID=16762503

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87306751T ATE62597T1 (de) 1986-09-19 1987-07-30 Ein neocarzinostatinderivat enthaltende zusammensetzungen zur oralen verabreichung.

Country Status (6)

Country Link
EP (1) EP0260796B1 (de)
JP (1) JP2556865B2 (de)
KR (1) KR950010320B1 (de)
AT (1) ATE62597T1 (de)
CA (1) CA1283359C (de)
DE (1) DE3769416D1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1327161C (en) * 1987-09-01 1994-02-22 Mitsugu Kobayashi Lyophilized pharmaceutical composition of neocarzinostatin derivative
WO1992005797A1 (en) * 1990-10-05 1992-04-16 Shingo Nagamitu Chemico-inmunological antineoplastic preparation
GB9613858D0 (en) * 1996-07-02 1996-09-04 Cortecs Ltd Hydrophobic preparations
PT1627645T (pt) * 2003-05-26 2017-11-23 Maeda Hiroshi Agente antitumoral e processo para a sua produção
WO2017191843A1 (ja) * 2016-05-06 2017-11-09 一般財団法人バイオダイナミックス研究所 高分子化薬物含有医薬組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6017206B2 (ja) * 1977-03-24 1985-05-01 浩 前田 ネオカルチノスタチン誘導体の製造法
US4578391A (en) * 1982-01-20 1986-03-25 Yamanouchi Pharmaceutical Co., Ltd. Oily compositions of antitumor drugs
EP0087957B1 (de) * 1982-02-27 1986-11-26 Kuraray Co., Ltd. Neocarzinostatinkomplexe, Verfahren zu ihrer Herstellung und Antitumormittel, das diese Komplexe als aktive Komponente enhält
JPS58149903A (ja) * 1982-02-27 1983-09-06 Kuraray Co Ltd ネオカルチノスタチン複合体の製造法
JPS59139396A (ja) * 1983-01-31 1984-08-10 Kuraray Co Ltd ネオカルチノスタチン複合体の製造方法
JPS6075432A (ja) * 1983-08-08 1985-04-27 Kuraray Co Ltd ネオカルチノスタチン誘導体及びその製造方法
JPS6075499A (ja) * 1983-08-08 1985-04-27 Kuraray Co Ltd ネオカルチノスタチン誘導体及びその製造法

Also Published As

Publication number Publication date
JPS6485922A (en) 1989-03-30
DE3769416D1 (de) 1991-05-23
JP2556865B2 (ja) 1996-11-27
KR950010320B1 (ko) 1995-09-14
KR880003631A (ko) 1988-05-28
EP0260796A1 (de) 1988-03-23
EP0260796B1 (de) 1991-04-17
CA1283359C (en) 1991-04-23

Similar Documents

Publication Publication Date Title
DE3873800D1 (de) Zusammensetzungen zur behandlung von hypercholesterinaemie.
DE3874250D1 (de) Anaesthesiemittel enthaltende kaugummi-zusammensetzungen.
PT84785B (pt) Processo para a preparacao de composicoes farmceuticas que contem omeprazole para administracao por via oral
DE3486235D1 (de) Fettsäure-Zusammensetzungen.
PT84786B (pt) Processo para a preparacao de composicoes farmaceuticas que contem compostos acidos labeis parea administracao por via oral
ATA195588A (de) Epipodophyllotoxinglucosid-4'-phosphat-derivate deren herstellung, sowie pharmazeutische zusammensetzungen hierzu
IL83349A (en) Stable pharmaceutical composition comprising cimetidine polymorph b suitable for oral administration
DK446684A (da) Farmaceutisk middel indeholdende et renset, afgiftet endotoksin i kombination med en pyridinoploeselig ekstrakt af en mikroorganisme
ES540172A0 (es) Procedimiento para produccion del compuesto (-)-trans-4-(4-fluorofenil)-3-(4-metoxifenoxi)metilpiperidina.
IT1206808B (it) Composizione orale antiplacca
DE69105697D1 (de) Nährungszusammensetzung und Verfahren zu ihrer Herstellung.
IT8748075A0 (it) Composizioni farmaceutiche a basedi chetotifene
ATE22532T1 (de) Pharmazeutische zusammensetzung.
ATE62597T1 (de) Ein neocarzinostatinderivat enthaltende zusammensetzungen zur oralen verabreichung.
DE3887068D1 (de) 2,2-Dimethylchromenderivate, Verfahren zur Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
MX164733B (es) Mejoras a composicion oral antiplaca
DE3586879D1 (de) Pyridinderivate und verfahren zu ihrer herstellung.
DE3682370D1 (de) 3-aminocarbonyl-1,4-dihydropyridin-5-carboxylsaeurederivate, verfahren zu ihrer herstellung, ihre verwendung und diese enthaltende pharmazeutische zusammensetzungen.
EP0207674A3 (en) 1,4-dihydropyridine derivatives, their preparation and their pharmaceutical use
DE3586817D1 (de) 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3673884D1 (de) Festes arzneimittel zur oralen verabreichung.
DE3686706D1 (de) Glaukomhemmende zusammensetzungen und verfahren zu ihrer herstellung.
FR2694005B1 (fr) Nouvelles aminoalkylchromones, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
IT8548306A0 (it) Composizione per la preparazione di un medicamento da usare per la cura della piorrea alveolare
ES2032838T3 (es) Un procedimiento para preparar derivados tetrahidropirido (1,2-a)indol.